Research Overview of IGF-1 LR3
IGF-1 LR3 is a recombinant long-acting variant of insulin-like growth factor-1, specifically engineered with structural modifications that extend its biological half-life compared to native IGF-1. This synthetic peptide incorporates an arginine substitution at position 3 and a 13-amino acid N-terminal extension, creating a research tool particularly valuable for investigating cellular growth mechanisms, protein synthesis pathways, and metabolic signalling networks. The LR3 variant demonstrates reduced binding affinity to IGF binding proteins, potentially allowing for enhanced bioavailability in experimental systems. Researchers at Stroid UK Shop obtain this compound for advanced peptide research protocols examining growth factor biology.
Laboratory Research Applications
Scientific investigations utilise IGF-1 LR3 to examine its role in cellular proliferation, differentiation, and survival pathways across various tissue types. Research applications include studying myocyte growth responses, investigating hepatocyte regeneration mechanisms, and analysing neuronal development processes in cell culture models. The compound serves as a valuable tool for examining mTOR signalling cascades, PI3K/Akt pathway activation, and MAPK-dependent cellular responses. Comparative studies often evaluate IGF-1 LR3 alongside compounds from our IGF-1 peptide collection to understand receptor binding specificity. Advanced research protocols incorporate IGF-1 LR3 in metabolic studies, examining its effects on glucose uptake, lipid metabolism, and protein synthesis regulation in controlled laboratory environments.
Technical Specifications
| Parameter | Value |
|---|---|
| Molecular Weight | 9117.5 g/mol |
| Amino Acid Length | 83 residues |
| CAS Number | 946870-92-4 |
| Purity Grade | ≥98% HPLC verified |
| Physical Form | Lyophilised white powder |
| Storage Conditions | -20°C, desiccated |
| Reconstitution | Sterile water or appropriate buffer |
| Stability | Extended when stored properly |
Our laboratory maintains strict quality control protocols ensuring each batch meets pharmaceutical-grade purity standards. Researchers studying growth factor mechanisms often combine IGF-1 LR3 investigations with compounds from our broader peptides range and SARMs collection for comprehensive experimental designs.
Research Compliance Statement
IGF-1 LR3 1mg from Ultima Pharmaceuticals is manufactured exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate institutional oversight, proper storage conditions, and adherence to local regulations governing peptide research compounds. All experimental protocols should follow established laboratory safety guidelines for handling recombinant peptides and maintain proper documentation of research activities.
